Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Headache, Hypoaesthesia, Immunisation, Paraesthesia
Clinical narrative: headache; bilateral burning of ears; spinal pain from mid back to neck; numbness and tingling in the injection arm; numbness and tingling in the injection arm; pain at injection site; Booster; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 38 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Jan2022 (Lot number: FD00809) at the age of 38 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing); "latex allergy" (unspecified if ongoing); "PCN allergy" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing); "bee venom allergy" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing); "almonds allergy" (unspecified if ongoing). Concomitant medication(s) included: FLUCONAZOLE; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; LOESTRIN. Past drug history included: Cefazolin, reaction(s): "Known allergies: cefazolin"; Midrin, reaction(s): "Known allergies: Midrin". Vaccination history included: Bnt162b2 (prev dose product=COVID 19, prev dose brand=Pfizer, prev dose brand unknown=False, prev dose lot number=EM9810, prev dose lot unknown=False, prev dose administration date=12Feb2021, prev dose dose number=2), administration date: 12Feb2021, when the patient was 38 years old, for COVID-19 immunization, reaction(s): "headache", "bilateral burning of ears", "spinal pain from mid back to neck", "numbness and tingling in the injection arm", "numbness and tingling in the injection arm"; Bnt162b2 (prev dose product=COVID 19, prev dose brand=Pfizer, prev dose brand unknown=False, prev dose lot number=EL3249, prev dose lot unknown=False, prev dose administration date=22Jan2021, prev dose dose number=1), administration date: 22Jan2021, when the patient was 38 years old, for COVID-19 immunization, reaction(s): "headache", "bilateral burning of ears", "spinal pain from mid back to neck", "numbness and tingling in the injection arm", "numbness and tingling in the injection arm". The following information was reported: IMMUNISATION (non-serious) with onset 10Jan2022, outcome "unknown", described as "Booster"; HEADACHE (non-serious) with onset 10Jan2022 14:00, outcome "unknown", described as "headache"; EAR DISCOMFORT (non-serious) with onset 10Jan2022 14:00, outcome "unknown", described as "bilateral burning of ears"; SPINAL PAIN (non-serious) with onset 10Jan2022 14:00, outcome "unknown", described as "spinal pain from mid back to neck"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 10Jan2022 14:00, outcome "unknown" and all described as "numbness and tingling in the injection arm"; VACCINATION SITE PAIN (non-serious) with onset 10Jan2022 14:00, outcome "unknown", described as "pain at injection site". It was unknown if therapeutic measures were taken as a result of headache, ear discomfort, spinal pain, hypoaesthesia, paraesthesia, vaccination site pain. No follow-up attempts are possible. No further information is expected.